Viewing Study NCT00174200



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00174200
Status: COMPLETED
Last Update Posted: 2008-07-15
First Post: 2005-09-09

Brief Title: Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone
Sponsor: Pfizer
Organization: Pfizer

Study Overview

Official Title: A Randomized Double-Blind Crossover Add-On Study To Assess The Differential Sensitivity Of 2 Spatial Working Memory Tests The Groton Maze Learning Test GMLT And The Motor Delayed Response Test MDR In Non-Agitated Antipsychotic Drug-Naive First-Episode Schizophrenic Or Schizophreniform Patients Treated With Risperidone 2 Mg Daily Or Placebo
Status: COMPLETED
Status Verified Date: 2008-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To assess the effect of risperidone 2 mg daily QD on the differential sensitivity of 2 spatial working memory tests the GMLT and MDR in non-agitated drug-naive patients suffering from first-episode schizophreniaschizophreniform disorder
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None